Literature DB >> 26839652

Brain changes in diabetes mellitus patients with gastrointestinal symptoms.

Anne M Drewes1, Eirik Søfteland1, Georg Dimcevski1, Adam D Farmer1, Christina Brock1, Jens B Frøkjær1, Klaus Krogh1, Asbjørn M Drewes1.   

Abstract

Diabetes mellitus is a common disease and its prevalence is increasing worldwide. In various studies up to 30%-70% of patients present dysfunction and complications related to the gut. To date several clinical studies have demonstrated that autonomic nervous system neuropathy and generalized neuropathy of the central nervous system (CNS) may play a major role. This systematic review provides an overview of the neurodegenerative changes that occur as a consequence of diabetes with a focus on the CNS changes and gastrointestinal (GI) dysfunction. Animal models where diabetes was induced experimentally support that the disease induces changes in CNS. Recent investigations with electroencephalography and functional brain imaging in patients with diabetes confirm these structural and functional brain changes. Encephalographic studies demonstrated that altered insular processing of sensory stimuli seems to be a key player in symptom generation. In fact one study indicated that the more GI symptoms the patients experienced, the deeper the insular electrical source was located. The electroencephalography was often used in combination with quantitative sensory testing mainly showing hyposensitivity to stimulation of GI organs. Imaging studies on patients with diabetes and GI symptoms mainly showed microstructural changes, especially in brain areas involved in visceral sensory processing. As the electrophysiological and imaging changes were associated with GI and autonomic symptoms they may represent a future therapeutic target for treating diabetics either pharmacologically or with neuromodulation.

Entities:  

Keywords:  Brain; Diabetes mellitus; Electroencephalogram; Gastrointestinal; Magnetic resonance imaging

Year:  2016        PMID: 26839652      PMCID: PMC4724575          DOI: 10.4239/wjd.v7.i2.14

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  79 in total

Review 1.  Cardiac autonomic diabetic neuropathy.

Authors:  Martin Schönauer; Andreas Thomas; Stephan Morbach; Josef Niebauer; Ulrike Schönauer; Holger Thiele
Journal:  Diab Vasc Dis Res       Date:  2008-11       Impact factor: 3.291

Review 2.  Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

Authors:  N E Cameron; S E Eaton; M A Cotter; S Tesfaye
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

Review 3.  Magnetic resonance imaging in the evaluation of cognitive function.

Authors:  Erin D Bigler
Journal:  Pediatr Blood Cancer       Date:  2014-06-11       Impact factor: 3.167

4.  Multimodal pain stimulations in patients with grade B oesophagitis.

Authors:  A M Drewes; H Reddy; J Pedersen; P Funch-Jensen; H Gregersen; L Arendt-Nielsen
Journal:  Gut       Date:  2005-08-09       Impact factor: 23.059

5.  Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life.

Authors:  D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; N Parker; S Kurth; S D Horn
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

6.  Impact of diabetes on CNS: role of signal transduction cascade.

Authors:  S K Bhardwaj; S K Sandhu; P Sharma; G Kaur
Journal:  Brain Res Bull       Date:  1999-06       Impact factor: 4.077

Review 7.  Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.

Authors:  Augustina M A Brands; Roy P C Kessels; Edward H F de Haan; L Jaap Kappelle; Geert Jan Biessels
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

8.  Association of type 2 diabetes with brain atrophy and cognitive impairment.

Authors:  Rosebud O Roberts; David S Knopman; Scott A Przybelski; Michelle M Mielke; Kejal Kantarci; Gregory M Preboske; Matthew L Senjem; Vernon S Pankratz; Yonas E Geda; Bradley F Boeve; Robert J Ivnik; Walter A Rocca; Ronald C Petersen; Clifford R Jack
Journal:  Neurology       Date:  2014-03-19       Impact factor: 9.910

9.  Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.

Authors:  C Jongen; J van der Grond; L J Kappelle; G J Biessels; M A Viergever; J P W Pluim
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

Review 10.  Diabetic neuropathy and oxidative stress: therapeutic perspectives.

Authors:  Asieh Hosseini; Mohammad Abdollahi
Journal:  Oxid Med Cell Longev       Date:  2013-04-24       Impact factor: 6.543

View more
  4 in total

Review 1.  Diabetes-induced mechanophysiological changes in the small intestine and colon.

Authors:  Mirabella Zhao; Donghua Liao; Jingbo Zhao
Journal:  World J Diabetes       Date:  2017-06-15

2.  Interdependency between mechanical parameters and afferent nerve discharge in remodeled diabetic Goto-Kakizaki rat intestine.

Authors:  Jingbo Zhao; Jian Yang; Donghua Liao; Hans Gregersen
Journal:  Clin Exp Gastroenterol       Date:  2017-12-01

3.  Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy.

Authors:  Christina Brock; Christian Stevns Hansen; Jesper Karmisholt; Holger Jon Møller; Anne Juhl; Adam Donald Farmer; Asbjørn Mohr Drewes; Sam Riahi; Hans Henrik Lervang; Poul Erik Jakobsen; Birgitte Brock
Journal:  Br J Clin Pharmacol       Date:  2019-08-30       Impact factor: 4.335

Review 4.  Neuromodulation of metabolic functions: from pharmaceuticals to bioelectronics to biocircuits.

Authors:  Benjamin J Seicol; Sebastian Bejarano; Nicholas Behnke; Liang Guo
Journal:  J Biol Eng       Date:  2019-08-01       Impact factor: 4.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.